Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 67.88% is 11505% above its 5-year average of 0.58%, around the middle of its 5-year range (-124.99%–278.07%).
43.11% above its 12-month average of 47.43%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 76.16%.
NET PROFIT MARGIN
67.88%
NET PROFIT MARGIN AVG TTM
47.43%
NET PROFIT MARGIN AVG 3Y
-2.15%
NET PROFIT MARGIN AVG 5Y
0.58%
NET PROFIT MARGIN AVG 10Y
3.19%
NET PROFIT MARGIN AVG 15Y
5.07%
NET PROFIT MARGIN AVG 20Y
4.25%
CURRENT VS TTM AVG
+43.11%
CURRENT VS 3Y AVG
+3259.92%
CURRENT VS 5Y AVG
+11505.42%
CURRENT VS 10Y AVG
+2025.11%
CURRENT VS 15Y AVG
+1239.95%
CURRENT VS 20Y AVG
+1496.32%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 703 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Ligand Pharmaceuticals Incorporated
Market Cap
$6.02B
Net Profit Margin
67.88%
TTM Avg
47.43%
3Y Avg
-2.15%
5Y Avg
0.58%
Market Cap
$6.02B
Net Profit Margin
-236.95%
TTM Avg
-945.70%
3Y Avg
-3296.24%
5Y Avg
-3620.73%
Market Cap
$5.94B
Net Profit Margin
-89.09%
TTM Avg
-187.61%
3Y Avg
-9430.16%
5Y Avg
-6286.77%
Market Cap
$5.83B
Net Profit Margin
-3602.68%
TTM Avg
-5857.26%
3Y Avg
-13524.50%
5Y Avg
-10844.39%
Market Cap
$5.82B
Net Profit Margin
9.59%
TTM Avg
-0.75%
3Y Avg
21.75%
5Y Avg
-53.79%
Market Cap
$5.55B
Net Profit Margin
-10.21%
TTM Avg
-9.94%
3Y Avg
-7.18%
5Y Avg
-7.18%
Market Cap
$6.51B
Net Profit Margin
17.69%
TTM Avg
17.76%
3Y Avg
15.93%
5Y Avg
7.17%
Market Cap
$6.55B
Net Profit Margin
5.05%
TTM Avg
-0.89%
3Y Avg
-2.79%
5Y Avg
-1.02%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ligand Pharmaceuticals Incorporated (LGND) | $6.02B | 67.88% | 47.43% | -2.15% | 0.58% |
| GRAIL Inc. (GRAL)vs › | $6.02B | -236.95% | -945.70% | -3296.24% | -3620.73% |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.94B | -89.09% | -187.61% | -9430.16% | -6286.77% |
| CG Oncology Inc. (CGON)vs › | $5.83B | -3602.68% | -5857.26% | -13524.50% | -10844.39% |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.82B | 9.59% | -0.75% | 21.75% | -53.79% |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.55B | -10.21% | -9.94% | -7.18% | -7.18% |
| RadNet, Inc. (RDNT)vs › | $5.54B | -0.93% | -0.38% | 0.04% | 0.11% |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.51B | 17.69% | 17.76% | 15.93% | 7.17% |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.55B | 5.05% | -0.89% | -2.79% | -1.02% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.60B | -5.51% | 7.00% | -0.29% | -8.82% |
Operating Margin
17.6%
Net Profit Margin
67.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 76.16% |
| 2026-03-31 | -25.80% |
| 2025-12-31 | 75.06% |
| 2025-09-30 | 101.57% |
| 2025-06-30 | 10.18% |
| 2025-03-31 | -93.64% |
| 2024-12-31 | -72.62% |
| 2024-09-30 | -13.84% |
| 2024-06-30 | -124.99% |
| 2024-03-31 | 278.07% |
| 2023-12-31 | 64.72% |
| 2023-09-30 | -31.26% |
| 2023-06-30 | 8.69% |
| 2023-03-31 | 95.38% |
| 2022-12-31 | -64.65% |
| 2022-09-30 | 0.68% |
| 2022-06-30 | -1.79% |
| 2022-03-31 | -42.13% |
| 2021-12-31 | -7.47% |
| 2021-09-30 | 21.17% |
| 2021-06-30 | 36.29% |
| 2021-03-31 | 32.83% |
| 2020-12-31 | 8.23% |
| 2020-09-30 | -16.01% |
| 2020-06-30 | 53.32% |
| 2020-03-31 | -72.77% |
| 2019-12-31 | -27.27% |
| 2019-09-30 | -61.48% |
| 2019-06-30 | -57.71% |
| 2019-03-31 | 1532.37% |
| 2018-12-31 | -71.29% |
| 2018-09-30 | 147.52% |
| 2018-06-30 | 81.25% |
| 2018-03-31 | 80.63% |
| 2017-12-31 | -13.89% |
| 2017-09-30 | 25.25% |
| 2017-06-30 | 21.64% |
| 2017-03-31 | 17.35% |
| 2016-12-31 | -8.18% |
| 2016-09-30 | 2.98% |
| 2016-06-30 | -29.52% |
| 2016-03-31 | 22.29% |
| 2015-12-31 | 29.92% |
| 2015-09-30 | 1125.16% |
| 2015-06-30 | 127.94% |
| 2015-03-31 | 5.16% |
| 2014-12-31 | 30.68% |
| 2014-09-30 | 8.55% |
| 2014-06-30 | 15.01% |
| 2014-03-31 | 13.14% |
| 2013-12-31 | 12.68% |
| 2013-09-30 | 15.11% |
| 2013-06-30 | 63.58% |
| 2013-03-31 | 12.83% |
| 2012-12-31 | 7.80% |
| 2012-09-30 | -3.04% |
| 2012-06-30 | -39.48% |
| 2012-03-31 | 20.10% |
| 2011-12-31 | 42.53% |
| 2011-09-30 | -68.04% |
| 2011-06-30 | -12.25% |
| 2011-03-31 | 247.05% |
| 2010-12-31 | 114.29% |
| 2010-09-30 | -151.79% |
| 2010-06-30 | -4.85% |
| 2010-03-31 | -46.16% |
| 2009-12-31 | 21.72% |
| 2009-09-30 | 22.82% |
| 2009-06-30 | -21.96% |
| 2009-03-31 | -54.02% |
| 2008-12-31 | -562.01% |
| 2008-09-30 | -345.37% |
| 2008-06-30 | -133.83% |
| 2008-03-31 | -80.69% |
| 2007-12-31 | 102.91% |
| 2007-09-30 | 22.78% |
| 2007-06-30 | 12.84% |
| 2007-03-31 | 116732.34% |
| 2006-12-31 | 414.19% |
| 2006-09-30 | -40.64% |
| 2006-06-30 | -32.94% |
| 2006-03-31 | -279.12% |
| 2005-12-31 | -5.55% |
| 2005-09-30 | -14.75% |
| 2005-06-30 | -19.49% |
| 2005-03-31 | -49.94% |
| 2004-12-31 | -29.77% |
| 2004-09-30 | -13.72% |
| 2004-06-30 | -35.14% |
| 2004-03-31 | -35.89% |
| 2003-12-31 | 10.32% |
| 2003-09-30 | -35.44% |
| 2003-06-30 | -41.19% |
| 2003-03-31 | -87.88% |
| 2002-12-31 | -24.62% |
| 2002-09-30 | -27.89% |
